{"company":{"id":2123105,"name":"Nuclera","domain":"nuclera.com","url":"https://alion.io/company/nuclera"},"section":"news","answer":"Nuclera: 25 headlines on record, 4 headlines in the last 90 days. Its story counts 8 milestones.","figures":[{"label":"Headlines","value":"25"},{"label":"In 90 days","value":"4"},{"label":"Milestones","value":"8"}],"blocks":[{"key":"news","title":"Headlines","source":"the outlets named on each headline, each story once","rows":18},{"key":"story","title":"Milestones","source":"Each milestone is dated by its source: registers, filings, the press","rows":8}],"news":[{"date":"2026-10-01","kind":"News","title":"Nuclera appoints Carl Raimond as Chief Executive Officer","source":"manchempharma","url":"https://manufacturingchemist.com/nuclera-appoints-carl-raimond-as-chief-executive-officer"},{"date":"2026-09-21","kind":"News","title":"Nuclera appoints Carl Raimond as Chief Executive Officer Cambridge Network","source":"cambridgenetwork.co.uk","url":"https://cambridgenetwork.co.uk/news/nuclera-appoints-carl-raimond-chief-executive-officer"},{"date":"2026-09-20","kind":"News","title":"Nuclera appoints ex-Thermo Fisher exec Carl Raimond as CEO","source":"businessweekly.co.uk","url":"https://businessweekly.co.uk/posts/nuclera-appoints-ex-thermo-fisher-exec-carl-raimond-as-ceo"},{"date":"2026-08-04","kind":"Blog","title":"Antibody Discovery: Cell-Free Protein Synthesis vs CHO Guide","url":"https://nuclera.com/antibody-discovery-cell-free-protein-synthesis-vs-cho-guide/"},{"date":"2026-07-10","kind":"Blog","title":"Built for AI Antibody Design. Accelerating the DBTL Cycle.","url":"https://nuclera.com/built-for-ai-antibody-design-accelerating-the-dbtl-cycle/"},{"date":"2026-06-04","kind":"Blog","title":"Overcoming the AI Antibody Validation Bottleneck with Early Hit Triage","url":"https://nuclera.com/overcoming-the-ai-antibody-validation-bottleneck-with-early-hit-triage/"},{"date":"2026-05-11","kind":"News","title":"Nuclera Launches Antibody Triage Service to Advance AI-Driven Antibody Discovery","source":"YahooFinance","url":"https://finance.yahoo.com/sectors/healthcare/articles/nuclera-launches-antibody-triage-advance-081700241.html"},{"date":"2026-03-30","kind":"Blog","title":"Nuclera launches GPCR-focused nanodisc panel to streamline membrane protein production","url":"https://nuclera.com/nuclera-launches-gpcr-focused-nanodisc-panel-to-streamline-membrane-protein-production/"},{"date":"2026-03-20","kind":"Blog","title":"Webinar recap: Frank Bernhard's Cell-Free Workflow for Cryo-EM-Ready Membrane Protein Complexes","url":"https://nuclera.com/webinar-recap-frank-bernhards-cell-free-workflow-for-cryo-em-ready-membrane-protein-complexes/"},{"date":"2026-03-09","kind":"Blog","title":"Bayer Crop Science: Accelerating membrane protein research for crop protection","url":"https://nuclera.com/bayer-crop-science-accelerating-membrane-protein-research-for-crop-protection/"},{"date":"2026-03-06","kind":"Blog","title":"A Faster Route to Active G-protein coupled receptors (GPCRs)","url":"https://nuclera.com/faster-route-functional-gpcrs/"},{"date":"2026-02-17","kind":"News","title":"Nuclera and leadXpro Partner to Accelerate Structure-Based Drug Design for Complex Membrane Proteins","source":"YahooFinance","url":"https://finance.yahoo.com/news/nuclera-leadxpro-partner-accelerate-structure-091800456.html"},{"date":"2026-01-13","kind":"News","title":"Nuclera Extends Series C Funding To $87 Million To Advance Antibody Engineering","source":"Pulse 2.0","url":"https://pulse2.com/nuclera-series-c-87-million/"},{"date":"2025-11-12","kind":"News","title":"Nuclera Expands eProtein Discovery Access in APAC Region","source":"technologynetworks.com","url":"https://technologynetworks.com/biopharma/product-news/nuclera-expands-eprotein-discovery-access-in-apac-region-406890"},{"date":"2025-06-02","kind":"News","title":"Nuclera and Cytiva Collaborate To Accelerate Characterization of Proteins for Drug Development","source":"technologynetworks.com","url":"https://technologynetworks.com/drug-discovery/product-news/nuclera-and-cytiva-collaborate-to-accelerate-characterization-of-proteins-for-drug-development-400464"},{"date":"2025-02-18","kind":"News","title":"Nuclera Appoints William J. Kullback as Non-Executive Director","source":"streetinsider.com","url":"https://streetinsider.com/Business+Wire/Nuclera+Appoints+William+J.+Kullback+as+Non-Executive+Director/24359616.html"},{"date":"2024-10-22","kind":"News","title":"Nuclera: Biotech Company Raises $75 Million For Accelerating Protein Expression","source":"Pulse 2.0","url":"https://pulse2.com/nuclera-biotech-company-raises-75-million-for-accelerating-protein-expression/"},{"date":"2021-05-12","kind":"Press release","title":"Nuclera Acquires E Ink Digital Microfluidics Unit","source":"businesswire.com","url":"https://businesswire.com/news/home/20210512005575/en/Nuclera-Acquires-E-Ink-Digital-Microfluidics-Unit"}],"story":[{"title":"New executive Nuclera appoints Carl Raimond as Chief Executive Officer · nuclera.com","url":"https://nuclera.com/nuclera-appoints-carl-raimond-as-chief-executive-officer/"},{"title":"Launched Nuclera launches antibody triage service to advance AI-driven antibody discovery · nuclera.com","url":"https://nuclera.com/nuclera-launches-antibody-triage-service-to-advance-ai-driven-antibody-discovery/"},{"title":"Raised a round Series C $12M · Pulse 2.0","url":"https://pulse2.com/nuclera-series-c-87-million/"},{"title":"Partnership Nuclera and Cytiva collaborate to accelerate characterization of proteins for drug development · the-scientist.com","url":"https://the-scientist.com/nuclera-and-cytiva-collaborate-to-accelerate-characterization-of-proteins-for-drug-development-73056"},{"title":"Board appointment Nuclera Appoints William J. Kullback as Non-Executive Director · streetinsider.com","url":"https://streetinsider.com/Business+Wire/Nuclera+Appoints+William+J.+Kullback+as+Non-Executive+Director/24359616.html"},{"title":"Raised a round Venture round $75M · led by Elevage Medical T · Pulse 2.0","url":"https://pulse2.com/nuclera-biotech-company-raises-75-million-for-accelerating-protein-expression/"},{"title":"Acquisition Nuclera Acquires E Ink Digital Microfluidics Unit · businesswire.com","url":"https://businesswire.com/news/home/20210512005575/en/Nuclera-Acquires-E-Ink-Digital-Microfluidics-Unit"},{"title":"Founded"}],"as_of":"2026-11-16","cite":"Nuclera, News. Alion, Nov 16, 2026. https://alion.io/company/nuclera/news","html_url":"https://alion.io/company/nuclera/news","json_url":"https://alion.io/company/nuclera/news.json","license":"CC BY-SA 4.0","meta":{"source":"Alion","generated_at":"2026-11-16T11:20:46Z"}}